Here are three more notes on the company’s 2023:
1. OrthAlign technology was used in 56,000 procedures worldwide in 2023 and more than 325,000 in total.
2. The company saw 37% revenue growth in the ASC field.
3. OrthAlign reported 27% growth in the U.S. market in 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
